EMD Millipore, Charles River sign licensing contract
The companies will collaborate to integrate the technology into viral clearance services provided by Charles River, which is designed to result in a consistent study outcome for clients.

The companies will collaborate to integrate the technology into viral clearance services provided by Charles River, which is designed to result in a consistent study outcome for clients.

The companies will develop disease models using diverse biologic data to elaborate disease-relevant mechanisms and find out potential new drug discovery opportunities. Selventa will leverage molecular patient data

Alacer produces nearly 500m packets of Emergen-C annually, and its products are sold in health food stores, supermarkets, drug stores, mass merchandisers and club stores. Emergen-C is an

The organic herbal lozenge is packed with a blend of organic herbal extracts nettle, eyebright, elderflower, plantain, vitamin C, and menthol. The company recommends the herbal product to

Sandoz Canada has stopped production at its plant in Quebec after the US Food and Drug Administration raised safety and reliability issues at the facility. Health Shared Services

The public entity has remained closed since 2011 after it incurred massive losses, the The Himalayan Times reported. The company had reported a cumulative loss of NPR485.85m ($6.64m)

The core technology is based on a novel antimicrobial targeting paradigm. The platform identifies and targets discrete amino acid insertion or deletion differences between essential homologous proteins that

The facility will manufacture the Ming Che product line of tailor-made lab water purification systems and consumables which will be sold exclusively in China. The products will cater

The European Medicines Agency’s (EMA) acceptance of the marketing authorization application (MAA) of peginesatide has triggered the milestone. Peginesatide, indicated to treat anemia associated with chronic kidney disease

Azul Instant is an all-natural supplement for erectile dysfunction (ED) developed by the comoany as an alternative to prescription drugs. The product carries no side effects, the company